Hypertension, Vol 19, 206-211, Copyright © 1992 by American Heart Association
M Kohno, T Horio, M Yoshiyama and T Takeda
Plasma concentrations of immunoreactive (ir) atrial (ANP) and brain (BNP)
natriuretic peptides were measured in the prehypertensive and hypertensive
phases in spontaneously hypertensive rats (SHR) and in the malignant phase
of hypertension caused by deoxycorticosterone acetate (DOCA)-salt in SHR.
The secretory rate of ANP and BNP were examined in the perfusion of
isolated beating heart before and after atrial removal. Plasma irANP and
irBNP in mature SHR were higher than those of control Wistar-Kyoto (WKY)
rats, whereas ANP and BNP values in young SHR did not differ from those of
control WKY rats. DOCA-salt treatment for 8 weeks markedly increased blood
pressure, ventricular weight, and plasma irANP and irBNP in SHR. ANP and
BNP values were positively correlated with ventricular weight in DOCA-salt
SHR. The secretory rate of ANP and BNP from the perfused whole heart were
much higher in DOCA- salt SHR than other rat groups. A large amount of BNP
was secreted from the hypertrophied ventricles in DOCA-salt SHR. In
contrast, ANP was mainly secreted from the atrium in all rat groups.
High-performance liquid chromatography profiles of extract in plasma showed
that a major component of irANP and irBNP corresponded to synthetic rat
ANP-(1-28) and rat BNP-45, respectively. Results suggest that both rat
ANP-(1-28) and rat BNP-45 are markedly increased in plasma in
DOCA-salt-induced malignant hypertension of SHR and that the major source
of circulating BNP is the hypertrophied ventricles in this model.
ARTICLES
Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension
First Department of Internal Medicine, Osaka City University Medical School, Japan.
This article has been cited by other articles:
![]() |
T. S. Mir, R. Laux, H. H. Hellwege, B. Liedke, C. Heinze, H. von Buelow, S. Laer, and J. Weil Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth Pediatrics, October 1, 2003; 112(4): 896 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Pemberton, T. G. Yandle, M. T. Rademaker, C. J. Charles, G. D. Aitken, and E. A. Espiner Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1200 - H1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Magga, O. Vuolteenaho, H. Tokola, M. Marttila, and H. Ruskoaho Involvement of Transcriptional and Posttranscriptional Mechanisms in Cardiac Overload–Induced Increase of B-Type Natriuretic Peptide Gene Expression Circ. Res., November 19, 1997; 81(5): 694 - 702. [Abstract] [Full Text] |
||||
![]() |
M. Marttila, O. Vuolteenaho, D. Ganten, K. Nakao, and H. Ruskoaho Synthesis and Secretion of Natriuretic Peptides in the Hypertensive TGR(mREN-2)27 Transgenic Rat Hypertension, December 1, 1996; 28(6): 995 - 1004. [Abstract] [Full Text] |
||||
![]() |
F. Liang, A. Atakilit, and D. G. Gardner Integrin Dependence of Brain Natriuretic Peptide Gene Promoter Activation by Mechanical Strain J. Biol. Chem., June 30, 2000; 275(27): 20355 - 20360. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |